Nearly 100 people attended today’s Florida Policy Forum on Clinical Trials in Jacksonville hosted by the American Cancer Society Cancer Action Network (ACS CAN). The event brought together Florida research experts, government officials, patients and leaders from the cancer community to raise awareness about clinical trials in the state and review strategies for recruiting more diverse participants.
NEW YORK, NY – August 28, 2017 – Mayor Bill de Blasio signed seven bills into law today aimed at reducing the use of dangerous tobacco products in New York City and to save lives.
WEST HARRISON, NY – Aug.
The Congressional Budget Office (CBO) today released its assessment of what would happen to health insurance premiums should the administration stop paying cost-sharing reductions (CSRs).
The CBO projects the average monthly premiums would increase 20 percent next year and 25 percent by 2020.
The New York City Council today passed seven bills that will take dramatic action to reduce the use of dangerous tobacco products in New York and to save lives.
On August 9, Oregon Governor Kate Brown signed into law legislation that will raise the state's age of sale for all tobacco products to age 21, making Oregon the fifth state to increase the tobacco sales age.
Baton Rouge, La. – East Baton Rouge Parish joined a growing list of the world’s great cities today when the Metropolitan Council voted 7-5 for a comprehensive smoke-free ordinance guaranteeing workers throughout East Baton Rouge Parish the right to breathe clean air.
An air quality study in Baton Rouge bars and casinos shows employees in those establishments are regularly exposed to unhealthy levels of air pollution and the only proven means to eliminate this exposure is to enact a comprehensive smoke-free air policy.
A majority of states are missing critical opportunities to pass and implement legislative solutions proven to prevent and fight cancer, according to the 15th annual How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality.
The Senate has advanced the U.S. Food and Drug Administration’s (FDA) Reauthorization Act, which expands four separate user fee agreements on new drugs, generic drugs, medical devices, and biosimilars, and includes a provision to maximize the development of therapies for children with cancer.